Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1212/wnl.94.15_supplement.4359

Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies (4359)

..., Stephen D. Silberstein
90
Neurology9.90
Volume: 94, Issue: 15_supplement
Published: Apr 14, 2020
Abstract
Sunday, April 26April 14, 2020Free AccessCardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies (4359)Stephanie J. Nahas, Yoel Kessler, Xiaoping Ning, Joshua M. Cohen, Verena Ramirez Campos, Ronghua Yang, and Stephen D. SilbersteinAuthors Info & AffiliationsApril 14, 2020 issue94 (15_supplement)https://doi.org/10.1212/WNL.94.15_supplement.4359 Letters to the...
Paper Fields
Paper Details
Title
Cardiovascular Safety of Fremanezumab in Patients with Episodic and Chronic Migraine: A Pooled Analysis of Phase 3 Studies (4359)
DOI
doi.org/10.1212/wnl.94.15_supplement.4359
Published Date
Apr 14, 2020
Journal
Neurology
Volume
94
Issue
15_supplement
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.